MedTrace Logo

Vascular Post Market Review

NCT02681341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2017-10-26

No results posted yet for this study

Summary

The primary objective of this study is to confirm that properties of CardioCel provide operative benefit to surgeons when compared to Dacron, CorMatrix, and all other bovine pericardium not treated with proprietary ADAPT engineering.

Conditions

  • Carotid Endarterectomy

Sponsors & Collaborators

  • Anteris Technologies Ltd.

    collaborator INDUSTRY

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Dennis Gable, MD · Baylor Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2017-04-24
Completion
2017-09-21

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02681341 on ClinicalTrials.gov